Paper17560621
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens.
Derby NR and 8 others. Virology, 2007. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens. Papers, record 17560621. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17560621
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antibodies, Viral | Major topic |
| Gene Products, env | Major topic |
| HIV-1 | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Cross Reactions | |
| Epitope Mapping | |
| Glycosylation | |
| HIV Envelope Protein gp41 | |
| Mice | |
| Molecular Sequence Data | |
| Neutralization Tests | |
| env Gene Products, Human Immunodeficiency Virus |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 AI007509 | NIAID NIH HHS | United States | T32AI007509 | PubMed and NIH | NIH RePORTER |
| R01 AI47708 | NIAID NIH HHS | United States | R01AI047708 | PubMed and NIH | NIH RePORTER |
| P30 AI027757 | NIAID NIH HHS | United States | P30AI027757 | PubMed and NIH | NIH RePORTER |
| AI007509 | NIAID NIH HHS | United States | T32AI007509 | PubMed and NIH | NIH RePORTER |
| P30 AI27757 | NIAID NIH HHS | United States | P30AI027757 | PubMed and NIH | NIH RePORTER |
| R01 AI047708 | NIAID NIH HHS | United States | R01AI047708 | PubMed and NIH | NIH RePORTER |
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16809318 | Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. | J Virol | 2006 | https://conductscience.org/library/papers/16809318 | PubMed |
| 2 | 9032336 | Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. | J Virol | 1997 | https://conductscience.org/library/papers/9032336 | PubMed |
| 3 | 16920175 | Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. | Virology | 2006 | https://conductscience.org/library/papers/16920175 | PubMed |
| 4 | 17046088 | Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope. | J Microbiol Methods | 2007 | https://conductscience.org/library/papers/17046088 | PubMed |
| 5 | 10890360 | Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates. | AIDS Res Hum Retroviruses | 2000 | https://conductscience.org/library/papers/10890360 | PubMed |
| 6 | 10888615 | V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. | J Virol | 2000 | https://conductscience.org/library/papers/10888615 | PubMed |
| 7 | 11069996 | The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. | J Virol | 2000 | https://conductscience.org/library/papers/11069996 | PubMed |
| 8 | 11134278 | Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. | J Virol | 2001 | https://conductscience.org/library/papers/11134278 | PubMed |
| 9 | 11152489 | Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. | J Virol | 2001 | https://conductscience.org/library/papers/11152489 | PubMed |
| 10 | 11356960 | The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. | J Virol | 2001 | https://conductscience.org/library/papers/11356960 | PubMed |
| 11 | 11485624 | Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region. | AIDS Res Hum Retroviruses | 2001 | https://conductscience.org/library/papers/11485624 | PubMed |
| 12 | 11602729 | Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. | J Virol | 2001 | https://conductscience.org/library/papers/11602729 | PubMed |
| 13 | 11997472 | Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/11997472 | PubMed |
| 14 | 12551968 | Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region. | J Virol | 2003 | https://conductscience.org/library/papers/12551968 | PubMed |
| 15 | 12646921 | Antibody neutralization and escape by HIV-1. | Nature | 2003 | https://conductscience.org/library/papers/12646921 | PubMed |
| 16 | 14512572 | Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate. | J Virol | 2003 | https://conductscience.org/library/papers/14512572 | PubMed |
| 17 | 14963123 | Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras. | J Virol | 2004 | https://conductscience.org/library/papers/14963123 | PubMed |
| 18 | 15016849 | N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies. | J Virol | 2004 | https://conductscience.org/library/papers/15016849 | PubMed |
| 19 | 15039757 | Identifying epitopes of HIV-1 that induce protective antibodies. | Nat Rev Immunol | 2004 | https://conductscience.org/library/papers/15039757 | PubMed |
| 20 | 15113902 | The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. | J Virol | 2004 | https://conductscience.org/library/papers/15113902 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26039641 | Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop. | PLoS One | 2015 | https://conductscience.org/library/papers/26039641 | PubMed |
| 25210191 | Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits. | J Virol | 2014 | https://conductscience.org/library/papers/25210191 | PubMed |
| 25043633 | Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection. | Eur J Immunol | 2014 | https://conductscience.org/library/papers/25043633 | PubMed |
| 24884925 | Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers. | Retrovirology | 2014 | https://conductscience.org/library/papers/24884925 | PubMed |
| 24872518 | Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits. | Clin Vaccine Immunol | 2014 | https://conductscience.org/library/papers/24872518 | PubMed |
| 24828352 | Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody. | PLoS One | 2014 | https://conductscience.org/library/papers/24828352 | PubMed |
| 22993152 | Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus. | J Virol | 2012 | https://conductscience.org/library/papers/22993152 | PubMed |
| 21430056 | Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodies. | J Virol | 2011 | https://conductscience.org/library/papers/21430056 | PubMed |
| 21249232 | Characteristics of the earliest cross-neutralizing antibody response to HIV-1. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/21249232 | PubMed |
| 20660181 | Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop. | J Virol | 2010 | https://conductscience.org/library/papers/20660181 | PubMed |
| 20510738 | Emerging studies of human HIV-specific antibody repertoires. | Vaccine | 2010 | https://conductscience.org/library/papers/20510738 | PubMed |
| 20053749 | Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs. | J Virol | 2010 | https://conductscience.org/library/papers/20053749 | PubMed |
| 19744690 | Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins. | Virology | 2009 | https://conductscience.org/library/papers/19744690 | PubMed |
| 19494007 | Introduction of exogenous epitopes in the variable regions of the human immunodeficiency virus type 1 envelope glycoprotein: effect on viral infectivity and the neutralization phenotype. | J Virol | 2009 | https://conductscience.org/library/papers/19494007 | PubMed |
| 18804254 | Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses. | Virology | 2008 | https://conductscience.org/library/papers/18804254 | PubMed |
| 18495775 | Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination. | J Virol | 2008 | https://conductscience.org/library/papers/18495775 | PubMed |
| 18003732 | The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous human immunodeficiency virus type 1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen. | J Virol | 2008 | https://conductscience.org/library/papers/18003732 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERVK-20 | 100616444 | PubTator's text mining | https://conductscience.org/library/genes/100616444 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17560621
GET https://conductscience.org/api/papers/v1/17560621/references?page=2